Online citations, reference lists, and bibliographies.
← Back to Search

Permeation Studies Of Indomethacin From Different Emulsions For Nasal Delivery And Their Possible Anti-Inflammatory Effects

H. Karasulu, Z. Şanal, S. Sözer, T. Güneri, G. Ertan
Published 2008 · Medicine, Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The purpose of this research was to develop an emulsion formulation of indomethacin (IND) suitable for nasal delivery. IND was incorporated into the oil phases of oil in water (O/W) and water in oil (W/O) emulsions. For this purpose, different emulsifying agents (Tween 80, Span 80 and Brij 58) were used in two emulsion formulations. When the effects of several synthetic membranes (nylon, cellulose, cellulose nitrate) were compared with the sheep nasal mucosa, the cellulose membrane and sheep nasal mucosa showed similar permeation properties for O/W emulsion (P > 0.05). To examine the absorption characteristics of IND, the anti-inflammatory properties of intravenous solution of IND, intranasal O/W emulsions of IND (with or without enhancers) and intranasal solution of IND (IND-Sol) were investigated in rats with carrageenan-induced paw edema. When citric acid was added to the nasal emulsion, the anti-inflammatory activity was similar to that of intravenous solution (P > 0.05). Finally, it was concluded that, intranasal administration of IND emulsion with citric acid may be considered as an alternative to intravenous and per oral administrations of IND to overcome their adverse effects.
This paper references
10.1016/0378-5173(89)90359-1
The influence of receptor fluid on in vitro percutaneous penetration
S. P. Jones (1989)
10.1016/S0378-5173(99)00018-6
Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits.
M. Ikechukwu Ugwoke (1999)
10.1016/S0378-5173(00)00506-8
Lipid emulsions as vehicles for enhanced nasal delivery of insulin.
R. Mitra (2000)
10.1016/S0378-5173(02)00540-9
Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels.
Jia-You Fang (2003)
Enhancement of nasal absorption of salmon calcitonin in rabbits using absorption enhancer
G. Yetkin (2001)
Nasal systemic drug delivery
Y. Chien (1989)
10.1016/0168-3659(94)00099-G
Vehicle influence on in vitro release of glucose : w/o, w/o/w and o/w systems compared
L. Ferreira (1995)
10.1002/JPS.2600760502
Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
J. Longenecker (1987)
10.1016/S0196-9781(97)00470-1
Permeation and Pathways of Human Calcitonin (hCT) Across Excised Bovine Nasal Mucosa
S. Lang (1998)
Novel approaches to nasal delivery of peptides and proteins
G. Tirucherai (2002)
10.1016/S0378-5173(02)00632-4
Microemulsions for topical delivery of estradiol.
S. Peltola (2003)
10.1016/J.COLSURFA.2004.09.029
Nano-emulsion formation by emulsion phase inversion
Patrick Fernandez (2004)
10.1016/S0168-3659(99)00031-0
Physiological mechanism for enhancement of paracellular drug transport.
M. Hayashi (1999)
preparation and in vitro characterization
C. Hascicek (2003)
10.1016/S0378-5173(01)00662-7
Effect of additives on insulin absorption from intratracheally administered dry powders in rats.
H. Todo (2001)
10.1016/J.IJPHARM.2004.05.009
Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.
M. Tafaghodi (2004)
Absorption of indomethacin from nasal cavity in rats.
Z. L. Huang (1995)
comparison with hydroxypropyl- and dimethyl-b-cyclodextrins
P. Sinswat (2003)
10.1016/S0169-409X(98)00073-8
Intranasal insulin delivery and therapy.
Hinchcliffe (1999)
10.1016/S0378-5173(01)00708-6
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
L. Illum (2001)
10.1016/S0014-827X(02)00004-6
Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization.
C. Hascicek (2003)
10.1016/S0378-5173(03)00090-5
Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Prapasri Sinswat (2003)
10.1016/S0168-3659(97)00253-8
Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium.
T. Kissel (1998)
10.1016/S0939-6411(03)00067-5
Solid lipid nanoparticle and microemulsion for topical delivery of triptolide.
Zhinan Mei (2003)
10.1208/pt070488
Transdermal delivery of diclofenac sodium through rat skin from various formulations
I. Özgüney (2008)
10.1016/J.JCONREL.2006.08.004
Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
T. Matsuyama (2006)
10.1016/J.IJPHARM.2003.10.024
Improvement of stability and absorbability of dry insulin powder for inhalation by powder-combination technique.
H. Todo (2004)
10.1016/S0014-827X(03)00080-6
In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives.
C. Taş (2003)
10.1080/03639040600975097
Enhancement of the Skin Permeation of Clindamycin Phosphate by Aerosol OT/1-Butanol Microemulsions
V. Junyaprasert (2007)
Drug release from pH-response polymer to nasal delivery
K. Alkawa (2002)
10.1016/S0927-7765(99)00048-X
Study on the formulation of o/w emulsion as carriers for lipophilic drugs
P. Kan (1999)



This paper is referenced by
10.2147/IJN.S193617
Integration of PEG 400 into a self-nanoemulsifying drug delivery system improves drug loading capacity and nasal mucosa permeability and prolongs the survival of rats with malignant brain tumors
Yu-Shuan Chen (2019)
10.1016/j.ejps.2012.10.029
Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa.
S. Pund (2013)
10.3109/03639045.2015.1135936
Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model
S. Mandal (2016)
10.1016/j.ijpharm.2018.07.065
Carrier free indomethacin microparticles for dry powder inhalation
N. E. Ceschan (2018)
10.3109/10717544.2014.920431
Nasal-nanotechnology: revolution for efficient therapeutics delivery
A. Kumar (2016)
10.1016/J.JDDST.2016.05.003
Formulation and device design to increase nose to brain drug delivery
Zachary N Warnken (2016)
10.1016/J.MOLLIQ.2013.01.008
Ultra fine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin
F. Shakeel (2013)
10.3109/03639045.2012.716444
Permeation of indomethacin from semisolid preparations through various semipermeable membranes
E. Tichý (2013)
10.1002/9781118971758.CH19
The Olfactory System as a Route of Delivery for Agents to the Brain and Circulation
M. Genter (2015)
10.1016/J.POWTEC.2015.02.001
Polymeric microparticles containing indomethacin for inhalatory administration
N. E. Ceschan (2015)
10.1016/j.ijpharm.2009.08.024
Novel dry powder inhaler formulation of glucagon with addition of citric acid for enhanced pulmonary delivery.
S. Onoue (2009)
Semantic Scholar Logo Some data provided by SemanticScholar